Letroheal 2.5 mg

Letroheal 2.5 mg Tablet contains letrozole an anti-cancer medicine used in the treatment of certain hormone-dependent breast cancers. It is commonly used for postmenopausal women with hormone receptor-positive early-stage, locally advanced or metastatic breast cancer.
Letroheal 2.5 mg works by reducing the amount of estrogen produced in the body. Since some breast cancer cells use estrogen to grow, lowering estrogen levels may help slow or prevent their growth.

Key Features

How does Letroheal 2.5 mg work?

After menopause much of the body’s estrogen is made when an enzyme called aromatase converts other hormones into estrogen. Letroheal blocks this enzyme, which lowers estrogen levels in the body.
This effect can be helpful when breast cancer cells are estrogen receptor-positive meaning they depend on estrogen signals for growth. By limiting estrogen availability letrozole may help reduce stimulation of these cancer cells.

Usage

Swallow Letroheal 2.5 mg whole with water. It can generally be taken with or without food, preferably at the same time each day. Do not stop treatment, change the dose or share the medicine with another person without medical advice.

Dosage 

The commonly recommended adult dose is one 2.5 mg tablet once daily. The oncologist should determine the exact duration of treatment based on the individual treatment plan and disease status.
If a dose is missed, take it when remembered unless it is almost time for the next dose. Do not take two tablets together to make up for a missed dose.

Side effects

Some people may experience:

• Hot flushes or sweating  
• Joint, muscle, or bone pain  
• Tiredness  
• Headache  
• Dizziness  
• Nausea or stomach discomfort  
• Swelling in the hands, feet, or ankles  
• Increased cholesterol levels  
• Reduced bone mineral density with long-term use 

Seek medical advice promptly for signs of an allergic reaction, severe chest pain, sudden breathlessness, unusual weakness, yellowing of the skin or eyes or persistent severe symptoms.

Interactions

Tell the doctor about all prescription medicines, supplements and herbal products you are using.
Major Drug Interactions

• Tamoxifen: Coadministration with tamoxifen significantly decreases the concentration of letrozole in your blood, making Letroheal substantially less effective. They should not be used together. 
• Estrogen-Containing Medications – Estrogens, such as hormone replacement therapy, birth control pills or vaginal creams, work against the action of Letroheal. They are counterproductive to the therapy and should be avoided. 
• Inhibitors of CYP3A4 and CYP2A6 – Some drugs (e.g. the antifungals ketoconazole or itraconazole) are powerful inhibitors of these liver enzymes, and may decrease the breakdown of letrozole. This may increase the amount of the medicine in your body and increase side effects.

Dietary and Lifestyle Interactions

• Food: There are no known food interactions with Letroheal. You may take the tablet with food or without food. Taking it with food may sometimes help minimize mild nausea or stomach upset.
• Alcohol: Alcohol does not directly alter the way that Letroheal works. However, alcohol may increase the usual side effects of the medication such as dizziness, drowsiness, flushing and fatigue.
• Herbal Supplements: You should avoid herbal remedies marketed for menopause symptoms (like black cohosh or red clover). Many of these supplements are estrogenic and can interfere with your treatment.

Pharmacokinetics

Detailed pharmacokinetic profile of Letroheal 2.5 mg:

• Bioavailability – Extremely high nearly 99.9% following oral administration.
• Food effect – Food slightly decreases the rate of absorption but does not affect the overall extent of absorption. It can be taken with or without food.

• Peak plasma concentration – Usually achieved in 1 to 2 hours (fasting) 
• Enzymes involved – The major metabolism is mediated by CYP3A4 and CYP2A6, which convert letrozole to an inactive carbinol metabolite.
• Half-life – The terminal elimination half-life is very long, in the order of 2 to 5 days.
• Excretion – Primarily cleared through the kidneys. Roughly 90% of the drug is recovered in urine, mainly as the inactive metabolite and its glucuronide conjugate. Only about 4% to 5% is excreted as unchanged letrozole.

Precautions

• Use only under the supervision of a qualified oncologist  
• Not recommended during pregnancy because it may harm the developing fetus  
• Effective contraception may be necessary for women with reproductive potential during treatment and for at least three weeks after stopping  
• Breastfeeding is not recommended during treatment and for three weeks after the last dose  
• Bone health may need monitoring during long-term therapy  
• Inform the doctor about liver disease, osteoporosis, high cholesterol or a history of fractures  
• Use caution if dizziness or tiredness affects driving or operating machinery 

Conclusion

Letroheal 2.5 mg contains letrozole, an aromatase inhibitor used for selected hormone receptor-positive breast cancers in postmenopausal women. It should be taken only under oncology supervision, with regular follow-up for treatment response, bone health, cholesterol levels and possible side effects.

FAQs